SCHEMBL7446013

SCHEMBL7446013

COc1ccc2c(C(=O)c3ccc(CN4CCOCC4)c(C)c3)c(-c3ccc(OCCN4CCCC4)cc3)sc2c1

nearest known ligand 0.71

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 15/20 0.71
ESR2 Q92731 14/20 0.71
ENPP1 P22413 3/20 0.63
ENPP3 O14638 3/20 0.63
STS P08842 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6595594 0.92 ESR1 (0.71) ESR1ESR2
SCHEMBL6596552 0.92 ESR1 (0.70) ESR1ESR2ENPP1ENPP3
SCHEMBL7444480 0.92 ESR1 (0.70) ESR1ESR2ENPP1ENPP3
SCHEMBL7774305 0.88 ESR1 (0.79) ESR1ESR2ENPP1ENPP3
SCHEMBL6597451 0.87 ESR1 (0.77) ESR1ESR2
SCHEMBL6597094 0.87 ESR1 (0.72) ESR1ESR2
SCHEMBL6598992 0.87 ESR1 (0.77) ESR1ESR2ENPP1ENPP3
SCHEMBL6598683 0.86 ESR1 (0.70) ESR1ESR2ENPP1ENPP3
SCHEMBL6173615 0.85 ESR1 (0.68) ESR1ESR2STS
SCHEMBL7768296 0.85 ESR1 (0.71) ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6265575-B1 THROMBIN INHIBITORS ELI LILLY AND COMPANY 2001-07-24 US disclosed
US-6251921-B1 ADMINISTERING THROMBIN INHIBITING DIAMINE COMPOUND TO MAMMAL ELI LILLY AND COMPANY 2001-06-26 US disclosed
US-6025382-A Antithrombotic diamines ELI LILLY AND COMPANY (US) 2000-02-15 US disclosed
EP-0863755-A4 ANTITHROMBOTIC DIAMINES LILLY CO ELI (US) 1999-01-20 EP disclosed
EP-0863755-A1 ANTITHROMBOTIC DIAMINES ELI LILLY AND COMPANY (US) 1998-09-16 EP disclosed
WO-1997025033-A1 ANTITHROMBOTIC DIAMINES ELI LILLY AND COMPANY (US) 1997-07-17 WO disclosed